NCT04217291View on ClinicalTrials.gov

The Efficacy and Safety of Different Doses of SY-004 in Patients With Type 2 Diabetes Mellitus

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 10, 2019

Primary Completion Date

July 9, 2021

Study Completion Date

July 9, 2021

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

SY-004

Take orally once a day

OTHER

SY-004 matching placebo

Take orally once a day

Trial Locations (1)

100853

PLA General Hospital, Beijing

All Listed Sponsors
lead

Suzhou Yabao Pharmaceutical R&D Co., Ltd.

INDUSTRY

NCT04217291 - The Efficacy and Safety of Different Doses of SY-004 in Patients With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter